Clinical Trials Browser

Not yet recruiting × Lymphoma, B-Cell, Marginal Zone × 30 days × Clear all

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT07592481 2026-05-22

HEMO-CONNECT

Hypertension, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT07583810 2026-05-15

Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma

Phase 2 Not yet recruiting

35 enrolled

Lymphoid

Lymphoma, Lymphoma, B-Cell, Marginal Zone

Clinical Trials

Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma

HEMO-CONNECT

Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma